Notice of AGM

Hutchison China Meditech Limited
12 April 2007



                  Hutchison China MediTech Limited ('Chi-Med')
                                   (AIM: HCM)

                        Annual Report and Accounts 2006
                        Notice of Annual General Meeting

London, Thursday, 12 April 2007: Chi-Med today announces that its Annual Report
and Accounts for the year ended 31 December 2006 together with the Notice of 
Annual General Meeting ('AGM') and the Proxy Form have been posted to 
shareholders.  The documents can be accessed from the website of Chi-Med 
(www.chi-med.com).

The AGM of Chi-Med will be held at Citigate Dewe Rogerson, 3 London Wall
Buildings, London, EC2M 5SY on Friday, 11 May 2007 at 2:30 p.m.

                                      Ends

Enquiries

Chi-Med                           Telephone: [phone]
Christian Hogg, CEO

Citigate Dewe Rogerson            Telephone: [phone]
Anthony Carlisle                  [phone]
Yvonne Alexander                  [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based
primarily in China and was admitted to trading on the Alternative Investment
Market of the London Stock Exchange in May 2006. Chi-Med is focused on
researching, developing, manufacturing, and selling pharmaceuticals, health
supplements and other consumer health and personal care products derived from
Traditional Chinese Medicine and botanical ingredients.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international
corporation listed on the Main Board of The Stock Exchange of Hong Kong Limited.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
 END
NOASFEFLFSWSEFL